Clinical trials
Observational Carcinoma, Hepatocellular trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2018 | 3 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 13 |
| Recruiting | 3 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hospital Universitario de Valme | 3 |
| Bayer | 2 |
| Hoffmann-La Roche | 2 |
| Cardiovascular and Interventional Radiological Society of Europe | 1 |
| Corporacion Parc Tauli | 1 |
| Eisai Inc. | 1 |
| Exact Sciences Corporation | 1 |
| Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 1 |
| Hospital Universitario La Paz | 1 |
| Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 19 |
| Liver Cirrhosis | 3 |
| Hepatitis C | 2 |
| Hepatitis C, Chronic | 2 |
| Liver Neoplasms | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Transitional Cell | 1 |
| Cardiovascular Diseases | 1 |
| Cholangiocarcinoma | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.